Prelude Therapeutics Incorporated
Hedge Funds Holdings
Last updated:
Prelude Therapeutics Incorporated‘s stocks are currently a part of 26 hedge funds’ portfolios, which represents 12.66% of the total amount of its stocks outstanding. This makes up a total of 5.99M shares of Prelude Therapeutics Incorporated. Compared to the previous quarter, the number fell by -80.76% or -25.18M shares fewer. As for the holding position changes, 26.92% (7) of current hedge fund investors increased the number of shares held, 30.77% (8) of current holders sold a part of the shares held, and 38.46% (10) closed the holdings completely. 2 hedge funds are new holders of Prelude Therapeutics Incorporated stock in Q1 2023, it is 7.69% of total holders.
Hedge funds holding Prelude Therapeutics Incorporated (Q3 2020 – Q1 2023)
| Q3 2020 | 38 |
|---|---|
| Q4 2020 | 51 |
| Q1 2021 | 60 |
| Q2 2021 | 57 |
| Q3 2021 | 61 |
| Q4 2021 | 75 |
| Q1 2022 | 66 |
| Q2 2022 | 57 |
| Q3 2022 | 50 |
| Q4 2022 | 60 |
| Q1 2023 | 26 |
Hedge funds changes in Prelude Therapeutics Incorporated positions (Q3 2020 – Q1 2023)
| Q3 2020 | 38 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2020 | 31 | 6 | 7 | 18 | -11 |
| Q1 2021 | 17 | 30 | 8 | 8 | -3 |
| Q2 2021 | 9 | 24 | 12 | 12 | 0 |
| Q3 2021 | 9 | 26 | 13 | 5 | 8 |
| Q4 2021 | 26 | 27 | 14 | 12 | -4 |
| Q1 2022 | 11 | 18 | 25 | 20 | -8 |
| Q2 2022 | 11 | 15 | 21 | 18 | -8 |
| Q3 2022 | 5 | 15 | 19 | 11 | 0 |
| Q4 2022 | 14 | 14 | 23 | 5 | 4 |
| Q1 2023 | 2 | 7 | 8 | 10 | -1 |
Hedge funds changes in Prelude Therapeutics Incorporated stock options (Q3 2020 – Q1 2023)
| Q3 2020 | 0 | 0 |
|---|---|---|
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 68,000 | 37,000 |
| Q1 2022 | 1,520,000 | 20,000 |
| Q2 2022 | 2,155,000 | 0 |
| Q3 2022 | 1,524,000 | 0 |
| Q4 2022 | 1,604 | 0 |
| Q1 2023 | 0 | 0 |